fbpx

Shedding light on Prostate Cancer with World leading Professor Mark Emberton.

More than 47,500 men are diagnosed with prostate cancer every year – that’s 129 men every day. Every 45 minutes one man dies from prostate cancer – that’s more than 11,500 men every year. 1 in 8 men will be diagnosed with prostate cancer in their lifetime. Around 400,000 men are living with and after prostate cancer.­– source Prostate Cancer UK


Rewatch this Live Event!

Join us as we interview one of the foremost speakers on the subject of prostate cancer in the world– Professor Mark Emberton Dean at UCL Faculty of Medical Sciences. He was interviewed by Dr Chris Manning from Sheddington. The interview included a Question and Answer section open to everyone watching.

The event was live on Thursday 25 February at 4PM on our Youtube Channel and our Facebook Page / Group channels where it can still be accessed. If you would like to learn more we recommend you getting in touch with Prostate Cancer UK.


Book a Session with Prostate Cancer UK

Prostate Cancer UK have a team of trained volunteers throughout the UK who carry out talks to groups both large and small (from a minimum of five people up to 100) and give you the information you need to know about prostate problems….https://prostatecanceruk.org/get-support/book-a-virtual-awareness-activity


More about our Hosts

Professor Mark Emberton:

Mark Emberton is a professor of Interventional Oncology and Dean of the UCL Faculty of Medical Sciences. 

He works as a clinician-scientist who combines practice-changing research with a state-of-the-art clinical practice that exploits many of the techniques and intervention that he was instrumental in developing. These areas include the use of MRI in the risk stratification of men with prostate cancer.  He was the earliest to adopt this technique.  It is now becoming a global standard of care.  His expertise in MRI drove the transition to image-directed prostate biopsy (that aims to reduce the burden of biopsy) and image-directed treatments (that aim to reduce the side-effects of treatment).  Mark has led most of the studies that led to the use of technologies capable of preserving prostate tissue.  These comprise High Intensity Focussed Ultrasound, Nanoknife electroporation and TookadTMVascular targeted phototherapy.

He continues his research programme that now focuses on early detection of cancer and completely new ways of treating cancer.  He holds a number of major grants and has published over 400 academic articles in many of the leading scientific journals.

He lectures widely, educates and trains the next generation of doctors and urologists, works with many charities and philanthropists to raise money for medical research and holds numerous leadership and advisory positions

Dr Chris Manning:

First and foremost the founder of Sheddington Men’s Shed in Teddington, Chris is a retired GP who is an incredible advocate for positive mental health and wellbeing. His bubble up and positive approach to our wellbeing sees Chris as the lead for Mental Health at the College of Medicine, he is Convenor at Action for NHS, Director of Upstream Healthcare Ltd and amongst his many other achievements was founder of Primhe, and former Chairman of the Depression Alliance. Chris is an active member of the UKMSA Health and Wellbeing Group and a great strength and advocate to the Men’s Shed movement.